Studies on Bone Markers and Bone Mineral Density in Patients with Chronic Renal Failure

Yonsei Medical Journal

Volumn 37, Issue 5, 1996, Pages 350-356

  Ha, Sung Kyu ^a,b   Park, Chong Hoon ^a   Seo, Jung Kun ^a   Park, Seung Ho ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Bone markers; Bone mineral density; Chronic renal failure; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; PARATHYROID HORMONE;

ARTICLE; BLOOD; BONE DENSITY; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLISM;

ALKALINE PHOSPHATASE; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE;

EID: 0030253346     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1996.37.5.350     Document Type: Article

References (22)

1. Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, Seto H, Sasayama S: Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol 38: 149-153, 1992
2. Chan TM, Pun KK, Cheng IKP: Total and regional bone densities in dialysis patients. Nephrol Dial Transplant 7: 835-839, 1992
3. 3 in chronic renal failure. Bone 14: 415-420, 1993
4. Coen G, Mazzaferro S, Coen G, Ballanti P, Bonucci E, Bondatti F, Manni M, Pasquali M, Perruzza I, Sardella D, Spurio A: Procollagen type 1 C-terminal extension peptide in predialysis chronic renal failure. Am J Nephrol 12: 246-251, 1992
5. Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME: Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in hemodialysis patients. Nephrol Dial Transplant 11: 1065-1072, 1996
6. Eknoyan G: Chronic renal failure. The primary care physician's role. Postgrad Med 79: 221-230, 1986
7. Fournier A, Yverneau PH, Hue P, Said S, Hamdini N, Eldin HH, Mohageb S, Oprisia R, Marie A, Solal ME: Adynamic bone disease in patients with uremia. Curr Opin Nephrol Hypertens 3: 396-410, 1994
8. Gabay C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R: Bone mineral density in patients with end-stage renal failure. Am J Nephrol 13: 115-123, 1993
9. Hamdy NAT, Risteli J, Risteli L, Harris S, Beneton MNC, Brown CB, Kanis JA: Serum type 1 procollagen peptide: a non-invasive index of bone formation in patients on hemodialysis? Nephrol Dial Transplant 9: 511-516, 1994
10. Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ: The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients. Pent Dial Int 16: 34-40, 1996
11. Johnston CC Jr, Slemenda CW, Melton LJ III: Clinical use of bone densitometry. N Engl J Med 324: 1105-1109, 1991
12. Mazzaferro S, Coen G, Ballanti P, Bondatti F, Bonucci E, Pasquali M, Sardella D, Tomei E, Taggi F: Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron 56: 261-266, 1990
13. Malluche HH, Faugere MC: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38: 193-211, 1990
14. Malluche HH, Faugere MC, Fanti P, Price PA: Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 26: 869-874, 1984
15. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30: 57-62, 1988
16. Ruedin P, Rizzoli R, Slosman D, Leski M, Bonjour JP: Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kideny Int 45: 245-252, 1994
17. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Serge GV, Goodman WG: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45: 253-258, 1994
18. Schmidt-Gayk H, Drueke T, Ritz E: Non-invasive circulating indicators of bone metabolism in uremic patients: can they replace bone biopsy? Nephrol Dial Transplant 11: 415-418, 1996
19. Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in end-stage renal failure. An evolving disorder. Kidney Int 43: 436-442, 1993
20. Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC: Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7: 506-512, 1996
21. Vaccaro F, Pagano A, Gioviale MC, Cavera S, Picone FP, Nigro RL, Buschemi G, Romano M, Filiberti S, Consolini P: Diagnostic value of pyndinolinic urinary collagen cross-links in hyperparathyroidism of kidney transplant patients. Dial Transplant 25: 132-140, 1996
22. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM: Prediction of postmenopausal fracture risk with use of bone mineral measurement. Am J Obstet Gynecol 153: 745-751, 1985